Our mission:
As OmniBiosystems, our mission is to improve human health by using human genetic and epigenetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant and challenging unmet medical needs. Achieving our goal starts with building multidisciplinary Research & Development (R&D) team that applies up to date genomics and proteomics tools in their translational research for the mission.

Our vision:
OmniBiosystems aspires to be among the top human therapeutics company within the next 5 years with assembled independent and interactive multidisciplinary group of scientists who together approach the challenge of drug discovery using multiple potential therapeutic modalities.

Our focus areas: OmniBiosytems research is primarily focused on Cancer molecular biology and Neuro-Degenerative diseases. Our research groups are actively engaged in novel approaches for these grievous diseases including elucidation of the epigenetic chromatin landscape as well as heretofore unapproached signaling pathways in aforementioned medical diseases.

Our approach:
OmniBiosystems' R&D engine is powered by independent, interactive and dedicated scientists. We are constantly bringing new ideas and work with new experts by closely collaborating with and/or supporting and outsourcing some of our research to number of national and international research groups on different projects.